Pharmazz partners with Sun Pharma to commercialise Tyvalzi in India
US-based biopharmaceutical company Pharmazz has signed a licence agreement with India’s Sun Pharmaceutical Industries to commercially launch its Tyvalzi (sovateltide) in India. Developed by Pharmazz, Tyvalzi is indicated